Table 3. Baseline Characteristics Grouped and by Major Adverse Cardiac Events (MACE).

Variable	Hazard Ratio	Confidence Interval	Chi-Square (x2)	p Value
Age of chemotherapy	0.00	0.97-1.02	0.001	0.97
Anthracycline dose	1.00	1.00-1.00	7.7	0.005
Male	0.68	0.28-1.69	0.69	0.40
Stage B heart failure	0.68	0.16-2.97	0.27	0.60
Stage C heart failure	1.48	0.38-6.43	0.27	0.60
Glomerular filtration rate	0.97	0.96-0.99	8.48	0.0003
Echocardiography:
Left ventricular ejection fraction	0.98	0.95-1.02	1.11	0.29
Estimated pulmonary artery systolic pressure	1.01	0.98-1.05	0.58	0.44
Indexed left ventricular mass by echocardiography	0.99	0.98-1.01	0.02	0.86
Cardiac Magnetic Resonance:
Left ventricular end diastolic volume	0.99	0.99-1.02	0.03	0.86
Left ventricular end systolic volume	1.01	0.99-1.02	1.73	0.52
Left ventricular ejection fraction	0.98	0.95-1.03	0.53	0.46
Indexed left ventricular mass by CMR	0.85	0.80-0.90	26.2	<0.0001
Right ventricular end diastolic volume	1.03	0.98-1.07	0.62	0.44
Right ventricular end systolic volume	1.01	0.99-1.02	1.83	0.18
Right ventricular ejection fraction	0.97	0.92-1.01	1.11	0.25